Related Experiment Video

Updated: Jul 10, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Calcineurin inhibitors block MHC-restricted antigen presentation in vivo

Young-Hee Lee1, Young-Ran Lee, Sun-A Im

  • 1College of Pharmacy, Chungbuk National University, Cheongju, South Korea.

Journal of Immunology (Baltimore, Md. : 1950)
|October 20, 2007
PubMed

Insights

Calcineurin inhibitors, like tacrolimus, block antigen presentation by antigen-presenting cells (APCs) in vivo. This immunosuppressive effect impacts both major histocompatibility complex (MHC) class I and class II pathways.

Area of Science:

  • Immunology
  • Pharmacology

Background:

  • Calcineurin inhibitors are crucial immunosuppressants.
  • Their effect on antigen-presenting cells (APCs) requires further elucidation.

Purpose of the Study:

  • To investigate the impact of calcineurin inhibitors on MHC-restricted exogenous antigen presentation in vivo.
  • To understand the mechanism of action of tacrolimus and cyclosporine A on APCs.

Main Methods:

  • Mice were treated with tacrolimus (FK-506) and soluble ovalbumin (OVA).
  • Dendritic cells (DCs) and peritoneal macrophages were isolated and assessed for OVA peptide presentation to T cells.
  • OVA-specific CD8 and CD4 T cell responses were evaluated.
  • Cyclosporine A was incorporated into microspheres with OVA to assess its effect on CTL induction.

Main Results:

  • Tacrolimus significantly inhibited MHC class I and class II restricted presentation of OVA by DCs and macrophages.
  • Tacrolimus-treated macrophages could still present synthetic OVA peptide (SIINFEKL).
  • Cyclosporine A co-administration with OVA in microspheres reduced OVA-specific CTL responses.

Conclusions:

  • Calcineurin inhibitors effectively block exogenous antigen presentation via both MHC class I and II pathways in vivo.
  • These findings offer new insights into calcineurin inhibitor action and have clinical implications for immunosuppression.

More Related Videos

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

Related Concept Videos

Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Antigen Processing Pathways01:31

Antigen Processing Pathways

MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...